Holdings
CapForce IBD Breakout Opportunities ETF
As of Jul 31, 2026, CapForce IBD Breakout Opportunities ETF reported 25 positions worth US$15.6M. Largest: Enliven Therapeutics, Inc., Bicara Therapeutics Inc. and U.s. Bancorp. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Enliven Therapeutics, Inc. | 21,441 | US$1.18M | new | Jul 31, 2026 |
| Bicara Therapeutics Inc. | 42,028 | US$1.14M | new | Jul 31, 2026 |
| U.s. Bancorp | 17,759 | US$1.12M | new | Jul 31, 2026 |
| Travere Therapeutics, Inc. | 19,803 | US$1.11M | new | Jul 31, 2026 |
| Waste Management, Inc. | 4,753 | US$1.08M | new | Jul 31, 2026 |
| Interface, Inc. | 29,561 | US$1.01M | new | Jul 31, 2026 |
| Ubs Group Ag | 18,795 | US$991K | new | Jul 31, 2026 |
| Goldman Sachs Group, Inc. (the) | 748 | US$762K | new | Jul 31, 2026 |
| Bank Of America Corporation | 12,087 | US$749K | new | Jul 31, 2026 |
| Pnc Financial Services Group, Inc. (the) | 2,981 | US$745K | new | Jul 31, 2026 |